Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance
- 2.2k Downloads
Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine.
Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor.
Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients.
This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.
KeywordsCirculating tumor cell Metastasis Clinical impact EMT Circulating cancer stem cell
This study was jointly supported by grants from the National Natural Science Foundation of China (No. 30973492, 81030038, 81000927, and 81071661), the National Key Sci-Tech Special Project of Infectious Diseases (No. 2008ZX10002-019 and 2008ZX10002-022), the Shanghai Rising-Star Follow-up Program Funds (No. 10QH1400500), and Research Fund for the Doctoral Program of Higher Education of China (20100071120064).
Conflict of interest
No potential conflicts of interest were disclosed.
- Chen TF, Jiang GL et al (2007) CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 56(1):105–114PubMedCrossRefGoogle Scholar
- Cristofanilli M (2009) The biological information obtainable from circulating tumor cells. Breast 18(suppl 3):S38–S40Google Scholar
- Davis JW, Nakanishi H et al (2008) Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. J Urol 179(6):2187–2191; discussion 2191Google Scholar
- Gradilone A, Raimondi C et al (2011) Circulating tumor cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. J Cell Mol Med 15(5):1066–1070Google Scholar
- Guzzo TJ, McNeil BK et al (2009) The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. Urol Oncol [Epub ahead of print]Google Scholar
- Hayes DF, Cristofanilli M et al (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12(14 Pt 1):4218–4224Google Scholar
- Hofman V, Ilie MI et al (2010) Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer [Epub ahead of print]Google Scholar
- Li G, Passebosc-Faure K et al (2005) Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells. Anticancer Res 25(1A):377–381Google Scholar
- Matsusaka S, Suenaga M et al (2011) Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer. Cancer Sci 102(6):1188–1192Google Scholar
- Raimondi C, Gradilone A et al (2011) Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat [Epub ahead of print]Google Scholar
- Sieuwerts AM, Mostert B et al (2011) mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 17(11):3600–3618Google Scholar
- Smit MA, Peeper DS (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene [Epub ahead of print]Google Scholar
- Stott SL, Lee RJ et al (2010b) Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2(25):25ra23Google Scholar
- Xu W, Cao L et al (2011) Isolation of circulating tumor cells in patients with hepatocellular carcinoma using an asialoglycoprotein receptor-based magnetic cell separation strategy. Clin Cancer Res 17(11):3783–3793Google Scholar
- Yang AD, Fan F et al (2006) Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 12(14 Pt 1):4147–4153Google Scholar